Sign Up to like & get recommendations! 0
Published in 2018 at "Leukemia research"
DOI: 10.1016/j.leukres.2018.10.018
Abstract: B cell acute lymphoblastic leukemia (B ALL) is a genetically heterogeneous neoplasm often demonstrating extensive subclone diversity within each patient's disease. The immunoglobulin heavy chain (IGH) locus is a marker of clonal variation in B… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Life sciences"
DOI: 10.1016/j.lfs.2020.118026
Abstract: AIM We aimed to determine the biological processes and pathways involved in cervical carcinogenesis associated with high-risk human papillomavirus (HPV) infection. MATERIALS AND METHODS Total RNA was extracted from three formalin-fixed paraffin-embedded (FFPE) samples each… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-04158-2
Abstract: Multiple myeloma (MM) is a heterogeneous disease, the full understanding of whose pathogenesis remains elusive. While B-cell receptors are known to play a pivotal role in myeloma pathogenesis, the characterization of immunoglobulin heavy-chain (IGH) gene… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Immunological Investigations"
DOI: 10.1080/08820139.2022.2092407
Abstract: ABSTRACT The outbreak and persistence of coronavirus disease 2019 (COVID-19) threaten human health. B cells play a vital role in fighting the infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite many studies… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "American Journal of Clinical Pathology"
DOI: 10.1093/ajcp/aqx105
Abstract: Objectives Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in Western populations, being rarer in Asian and African people. It has been suggested that patients with CLL from Africa might have a… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000015811
Abstract: Abstract Immunoglobulin heavy chain variable region (IGHV) gene mutation status is a biomarker for the prognosis of chronic lymphocytic leukemia, whether it is associated with the diagnosis, staging, and prognosis of patients with mantle cell… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Cold Spring Harbor protocols"
DOI: 10.1101/pdb.prot107750
Abstract: B cells undergo a process of somatic recombination leading to the synthesis of a staggering diversity of transmembrane and secreted antibodies. This process dates back to the evolution of jawed vertebrates and is pivotal to… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007279
Abstract: Key Points We unveil the distinct patterns of IGHV repertoire and discuss the correlation between IGHV and other genetic abnormalities in LPL/WM. IGHV4 usage was a predictive marker of shorter progression-free survival in patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.02136
Abstract: An incomplete ascertainment of genetic variation within the highly polymorphic immunoglobulin heavy chain locus (IGH) has hindered our ability to define genetic factors that influence antibody-mediated processes. Due to locus complexity, standard high-throughput approaches have… read more here.